Our results are consistent with an analysis of the Women’s Health Initiative, which showed that the BCRAT model predicted ER+ breast cancers, but not ER− breast cancers [21] and with our prior analysis with a smaller sample [11]. Here, ESR1 is linked to breast carcinoma.